HPV, câncer e profilaxia: uma abordagem geral

Abstract

With a large number of disease cases attributed to human papillomavirus (HPV) worldwide, it becomes clear that there is a real need to develop strategies in the field of health and education to promote a significant reduction in viral occurrence of different types of cancer that annually make hundreds of fatal victims. Even with the relation of the virus to the pathologies already characterized for years, the number of infections still remains high, with sexual transmission being the most important. After the development of diagnostic techniques for the evaluation of precursor cell changes of carcinoma and the development of prophylactic vaccines, it is understood that adherence by preventive measures by the population tends to be intrinsically related to the knowledge about the main damages caused by HPV. The development of prophylactic vaccines provides a decrease in the incidence of cell changes associated with cancer. An association between existing prophylactic measures and continued biotechnological development promises to transpose current viral infection rates. After extensive bibliography review, it was possible to verify that the knowledge about the papillomavirus is broad and consolidated, which allows the development of effective prophylactic strategies, including vaccines and the screening of precursor lesions of carcinomas. The biotechnological development related to HPV has a great impact on public health and has been improving over the years, with scientific research that enables the development of promising prophylactic and therapeutic strategies against HPV. However, communication with the individuals has a significant impact on the understanding of the importance of vaccination, evidenced by the low vaccination coverage, evidencing the lack of a wide dissemination to the population of accurate information about the virus and potential pathologies.